EZVille, Ltd. Recalls Solo Slim Over Undeclared Ingredient

On August 6, 2010, EZVille, Ltd. issued a voluntary recall of its Solo Slim weight loss supplement products after being informed by the FDA that the supplement was found to contain an undeclared ingredient. Lab tests revealed that Solo Slim contained Didesmethyl Sibutramine, which is an FDA approved ingredient for suppressing appetite in weight loss drugs. Solo Slim has not been approved by the FDA, a Safety Alert article noted.

The article states, “FDA advises that Solo Slim® poses a threat to consumers because Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.”

EZVille advised consumers to stop taking Solo Slim and to return all unused portions of the supplement to the company or to the store of purchase for a full refund. They further advised customers to report any illnesses or adverse side effects related to use of Solo Slim to their physicians, the FDA, and EZVille immediately.

The Solo Slim products were sold in retail stores, through websites, and to distributors across the United States.

References:

Budzinski, Eric. (August 6, 2010) “EZVille, Ltd. Issues a Voluntary Nationwide Recall of Solo Slim® Found to Contain an Undeclared Drug Ingredient.” Retrieved on August 26, 2010 from the FDA web site.